Squalene epoxidase Antibodies

Santa Cruz Biotechnology features a diverse variety of Squalene Epoxidase monoclonal antibodies for investigating squalene epoxidase in various biological processes. Squalene epoxidase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Squalene epoxidase is a key enzyme in the cholesterol biosynthesis pathway, catalyzing the conversion of squalene to 2,3-oxidosqualene. The enzyme plays a crucial role in the regulation of lipid metabolism and influences cell membrane integrity and signaling. Dysregulation of squalene epoxidase has been associated with several diseases, making it an important target for therapeutic intervention. Research has shown that squalene epoxidase activity is essential for maintaining cellular homeostasis and proper lipid distribution. Understanding squalene epoxidase function can provide insights into metabolic disorders and potential treatment strategies. Recent studies have highlighted the significance of squalene epoxidase in cancer development and progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of lipid metabolism and its implications in health and disease.